摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

((1R)-1-{[(benzyloxy)carbonyl]amino}-3-phenylpropyl)phosphinic acid | 924896-60-6

中文名称
——
中文别名
——
英文名称
((1R)-1-{[(benzyloxy)carbonyl]amino}-3-phenylpropyl)phosphinic acid
英文别名
(1-(((benzyloxy)carbonyl)amino)-3-phenylpropyl)phosphinic acid
((1R)-1-{[(benzyloxy)carbonyl]amino}-3-phenylpropyl)phosphinic acid化学式
CAS
924896-60-6
化学式
C17H20NO4P
mdl
——
分子量
333.324
InChiKey
NKIJHPAMPARFRD-MRXNPFEDSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.34
  • 重原子数:
    23.0
  • 可旋转键数:
    7.0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.24
  • 拓扑面积:
    75.63
  • 氢给体数:
    2.0
  • 氢受体数:
    3.0

反应信息

  • 作为反应物:
    描述:
    ((1R)-1-{[(benzyloxy)carbonyl]amino}-3-phenylpropyl)phosphinic acid氢溴酸1-羟基苯并三唑盐酸-N-乙基-Nˊ-(3-二甲氨基丙基)碳二亚胺N,N-二异丙基乙胺六甲基二硅氮烷 作用下, 以 二氯甲烷溶剂黄146 为溶剂, 反应 55.33h, 生成 ((1R)-1-amino-3-phenylpropyl){2′-[((2″S)-1″-amino-4″-methyl-1″-oxopentan-2″-yl)carbamoyl]-4′,4′-diphenylbutyl}phosphinic acid
    参考文献:
    名称:
    Optimization and Structure–Activity Relationships of Phosphinic Pseudotripeptide Inhibitors of Aminopeptidases That Generate Antigenic Peptides
    摘要:
    The oxytocinase subfamily of M1 aminopeptidases, Consisting of ER aminopeptidase 1 (ERAP1), ER aminopeptidase 2 (ERAP2), and insulin-regulated aminopeptidase (IRAP), plays critical roles in the generation of antigenic peptides and indirectly regulates human adaptive immune responses. We have previously,demonstrated that phosphinic pseudotripeptides can constitute potent inhibitors of this group of enzymes. In this study, we used synthetic methodologies able to furnish a series of stereochemically defined phosphinic pseudotripeptides and demonstrate that side chains at P-1' and P-2' positions are Critical determinants in driving potency and selectivity. We identified low nanomolar inhibitors of ERAP2 and IRAP that display selectivity of more than 2 and 3 orders of magnitude, respectively. Cellular analysis demonstrated that one of the compounds that is a selective IRAP inhibitor can reduce IRAP-dependent but not, ERAP1-dependent cross-presentation by dendritic cells with nanomolar efficacy. Our results encourage further preclinical development of phosphinic pseudotripeptides as regulators of adaptive immune responses.
    DOI:
    10.1021/acs.jmedchem.6b01031
  • 作为产物:
    描述:
    参考文献:
    名称:
    研究次膦酸三肽模拟物 DG013A 作为 M1-氨基肽酶 ERAP1 的工具化合物抑制剂
    摘要:
    ERAP1 是一种锌依赖性 M1-氨基肽酶,可从肽的N末端修剪亲脂性氨基酸。由于其在抗原加工和适应性免疫反应调节中的重要性,高度多态性 ERAP1 的失调与自身免疫性疾病和癌症有关。为了检验这一假设并确定 ERAP1 在这些疾病领域的作用,高亲和力、细胞渗透性和选择性的化学探针至关重要。 DG013A 1是一种次膦酸三肽模拟抑制剂,据报道对 ERAP1 具有低纳摩尔亲和力。然而,这种化学型是与各种金属依赖性肽酶结合的特殊结构,并且含有高电荷次膦酸部分,因此尚不清楚它是否会表现出化学探针所需的高选择性和被动渗透性。因此,我们设计了一种新的立体选择性路线来合成 DG013A 1类似物库,以确定该化合物作为细胞化学探针的适用性,以验证 ERAP1 作为药物发现靶点。
    DOI:
    10.1016/j.bmcl.2021.128050
点击查看最新优质反应信息

文献信息

  • Practical Synthesis of Phosphinic Dipeptides by Tandem Esterification of Aminophosphinic and Acrylic Acids under Silylating Conditions
    作者:Paraskevi Kokkala、Kostas Voreakos、Angelos Lelis、Konstantinos Patiniotis、Nikolaos Skoulikas、Laurent Devel、Angeliki Ziotopoulou、Eleni Kaloumenou、Dimitris Georgiadis
    DOI:10.3390/molecules27041242
    日期:——
    acrylic acids and (R)-α-aminophosphinic acids, and high yields were achieved in all cases. In most examples reported herein, the isolation of biologically relevant (R,S)-diastereoisomers became possible by simple crystallization from the crude products, thus enhancing the operational simplicity of the proposed method. Finally, functional groups corresponding to acidic or basic natural amino acids are also
    在本报告中,提出了一种制备 5 型次膦酸二肽的合成方案。这些化合物可作为开发药用相关蛋白酶和天冬蛋白酶的高效膦肽抑制剂的重要组成部分。所提出的方法基于 α-次膦酸丙烯酸在甲硅烷基化条件下的串联酯化,以便随后参与 P-Michael 反应。通过使用多种容易获得的丙烯酸和 (R)-α-次膦酸来研究转化的范围,并且在所有情况下都实现了高产率。在本文报道的大多数例子中,生物学相关的 (R,S)-非对映异构体的分离成为可能通过从粗产物中简单结晶,从而提高了所提出方法的操作简单性。最后,对应于酸性或碱性天然氨基酸的官能团也与反应条件相容。基于以上所述,我们预计所提出协议的实用性将有助于发现药理上有用的生物活性次膦酸肽。
  • ERAP2 Inhibition Induces Cell-Surface Presentation by MOLT-4 Leukemia Cancer Cells of Many Novel and Potentially Antigenic Peptides
    作者:Ioannis Temponeras、George Stamatakis、Martina Samiotaki、Dimitris Georgiadis、Harris Pratsinis、George Panayotou、Efstratios Stratikos
    DOI:10.3390/ijms23031913
    日期:——

    Recent studies have linked the activity of ER aminopeptidase 2 (ERAP2) to increased efficacy of immune-checkpoint inhibitor cancer immunotherapy, suggesting that pharmacological inhibition of ERAP2 could have important therapeutic implications. To explore the effects of ERAP2 inhibition on the immunopeptidome of cancer cells, we treated MOLT-4 T lymphoblast leukemia cells with a recently developed selective ERAP2 inhibitor, isolated Major Histocompatibility class I molecules (MHCI), and sequenced bound peptides by liquid chromatography tandem mass spectrometry. Inhibitor treatment induced significant shifts on the immunopeptidome so that more than 20% of detected peptides were either novel or significantly upregulated. Most of the inhibitor-induced peptides were 9mers and had sequence motifs and predicted affinity consistent with being optimal ligands for at least one of the MHCI alleles carried by MOLT-4 cells. Such inhibitor-induced peptides could serve as triggers for novel cytotoxic responses against cancer cells and synergize with the therapeutic effect of immune-checkpoint inhibitors.

    最近的研究将ER肽酶2(ERAP2)的活性与免疫检查点抑制剂癌症免疫治疗的疗效增加联系起来,表明ERAP2的药物抑制可能具有重要的治疗意义。为了探索ERAP2抑制对癌细胞免疫肽组的影响,我们使用最近开发的选择性ERAP2抑制剂处理MOLT-4 T淋巴母细胞白血病细胞,分离主要组织相容性I类分子(MHCI),并通过液相色谱串联质谱法对结合的肽进行测序。抑制剂处理引起了免疫肽组的显著变化,以至于检测到的肽中有超过20%是新颖的或明显上调的。大多数抑制剂诱导的肽是9mers,并具有序列模体和预测亲和力,与MOLT-4细胞携带的至少一种MHCI等位基因的最佳配体一致。这样的抑制剂诱导肽可能作为诱发对癌细胞的新型细胞毒反应的触发器,并与免疫检查点抑制剂的治疗效果协同作用。
  • Diastereoselective Synthesis of Phosphinic Dipeptide Isosteres: Domino Chirality Transfer during a Stereocontrolled P-Michael Reaction
    作者:Angelos Lelis、Nikolaos Skoulikas、Mirto Papathanasopoulou、Kostas Voreakos、Dimitris Georgiadis
    DOI:10.1021/acs.orglett.3c02335
    日期:2023.9.15
    A highly diastereoselective P-Michael addition of chiral aminophosphinic acids to achiral acrylates has been developed, leading to phosphinic dipeptide isosteres in high yields and dr of up to >50:1. The method allows for the diastereoselective preparation of target compounds without the need for chiral auxiliaries or P-chiral substrates. A possible mechanistic explanation involves a domino chirality
    已开发出手性次膦酸与非手性丙烯酸酯的高度非对映选择性 P-Michael 加成反应,可产生高产率的次膦二肽电子等排体,dr 高达 >50:1。该方法允许非对映选择性制备目标化合物,而不需要手性助剂或 P-手性底物。一种可能的机制解释涉及从次膦酸到 P 中心的多米诺骨牌手性转移,通过关键的二苯甲基酯基团放大,然后转移到 α-碳。
  • Late-Stage Diversification of Phosphinic Dehydroalanine Pseudopeptides Based on a Giese-Type Radical C-Alkylation Strategy
    作者:Kostas Voreakos、Laurent Devel、Dimitris Georgiadis
    DOI:10.1021/acs.orglett.9b00857
    日期:2019.6.21
    A straightforward, late-stage diversification strategy for the installation of side chains on readily accessible unsaturated phosphinopeptidic scaffolds based on a Giese-type addition of alkyl radicals has been investigated. Among different alternatives, the preferred methodology is operationally simple as it can be carried out in an open flask with no need for protection of acidic moieties. Direct application to the synthesis of SPPS-compatible building blocks or to longer peptides is also reported.
  • High-performance liquid chromatographic enantiomer separation and determination of absolute configurations of phosphinic acid analogues of dipeptides and their α-aminophosphinic acid precursors
    作者:Michael Lämmerhofer、Dieter Hebenstreit、Elena Gavioli、Wolfgang Lindner、Artur Mucha、Paweł Kafarski、Piotr Wieczorek
    DOI:10.1016/s0957-4166(03)00537-8
    日期:2003.9
    The enantiomers of N-benzyloxycarbonyl-phospinic pseudodipeptides and their N-benzyloxycarbonyl-alpha-aminophosphinic acid precursors as well as various other structural analogues were separated oil a set of cinchona alkaloid-derived chiral anion-exchangers by HPLC in the reversed-phase mode. Semi-preparative scale chromatography provided single enantiomers in 100 mg quantities. The configurations of the enantiomers were assigned indirectly by enantioselective chromatography on the basis of the elution order and was confirmed by enantiomeric reference compounds. (C) 2003 Elsevier Ltd. All rights reserved.
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫